Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ReposiTrak filings document a Nevada operating company that provides SaaS-based traceability, compliance, risk management, and supply chain applications for retailers, wholesalers, suppliers, and food manufacturers. Its Form 8-K disclosures record quarterly results and earnings-call materials, cash dividend declarations, share repurchase authorizations, and material commercial or financing agreements involving its subsidiary PC Group.
Governance filings cover director appointments, committee assignments, annual meeting voting results, executive compensation advisory votes, and common-stock matters. The disclosures also describe the company's product families, public-company governance framework, capital allocation actions, and regulatory context for food safety and supply chain compliance.
ReposiTrak, Inc.’s chief executive officer, director, and 10% owner Randall K. Fields reported an automatic sale of common stock by an affiliated charitable entity. On January 26, 2026, RK Fields Charitable 2022, LLC sold 7,500 shares of ReposiTrak common stock at a weighted average price of $11.0742 per share under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After this sale, RK Fields Charitable 2022, LLC held 130,000 common shares. Fields also reported 3,483,955 common shares held directly, and indirect common holdings including 615,260 shares through Riverview Financial Corp., 30,667 shares by his spouse, and 333,643 shares through Fields Management, Inc., plus Series B Preferred Stock held indirectly via Riverview Financial Corp. and his spouse.
ReposiTrak, Inc.’s chief executive officer, director, and 10% owner Randall K. Fields reported an automatic sale of common stock by an affiliated charitable entity. On January 26, 2026, RK Fields Charitable 2022, LLC sold 7,500 shares of ReposiTrak common stock at a weighted average price of $11.0742 per share under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After this sale, RK Fields Charitable 2022, LLC held 130,000 common shares. Fields also reported 3,483,955 common shares held directly, and indirect common holdings including 615,260 shares through Riverview Financial Corp., 30,667 shares by his spouse, and 333,643 shares through Fields Management, Inc., plus Series B Preferred Stock held indirectly via Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider holdings data show that RK Fields Charitable 2022, LLC, an entity associated with CEO, director and 10% owner Randall K. Fields, sold common stock in two Rule 10b5-1 plan transactions. The LLC sold 2,500 shares of common stock on January 20, 2026 at a weighted average price of $10.9697, and 5,000 shares on January 21, 2026 at a weighted average price of $10.9106. These sales were made under a pre-established Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments, and the LLC now holds 137,500 common shares. Fields also reports additional ownership of ReposiTrak securities, including 3,483,955 common shares held directly, further common shares held through entities such as Riverview Financial Corp., his spouse and Fields Management, Inc., and Series B Preferred Stock held indirectly through Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider filing shows planned charitable-related stock sales by entities associated with CEO and 10% owner Randall K. Fields. A Rule 10b5-1 trading plan for RK Fields Charitable 2022, LLC executed sales of ReposiTrak common stock on three days: 1,000 shares on 01/14/2026 at a weighted average price of $11.094, 3,600 shares on 01/15/2026 at $11.0786, and 2,900 shares on 01/16/2026 at $10.8452. The trading plan was established to help the reporting person meet charitable commitments.
After these transactions, RK Fields Charitable 2022, LLC held 145,000 shares of common stock. As of 01/14/2026, Randall K. Fields also beneficially owned 3,483,955 common shares directly, plus additional common and Series B preferred stock indirectly through Riverview Financial Corp., his spouse, Fields Management, Inc., and other related holdings.
ReposiTrak director Robert W. Allen reported selling 8,280 shares of Series B Preferred Stock at $10.70 per share on 12/31/2025. After this transaction, he directly held 22,411 shares of Series B Preferred Stock. He also reported direct ownership of 199,147 shares of common stock, plus indirect holdings of 587,476 common shares through a trust and 2,775 common shares held by his spouse.
ReposiTrak, Inc. insider activity shows several transactions by entities associated with Chief Executive Officer Randall K. Fields, who is also a director and 10% owner. RK Fields Charitable 2022, LLC sold 5,000 shares of common stock on January 5, 2026 at a weighted average price of $12.2686 per share and 2,500 shares on January 6, 2026 at a weighted average price of $11.7238 per share under a pre-arranged Rule 10b5-1 trading plan set up to help meet charitable commitments. After these sales, this LLC held 155,000 and then 152,500 common shares. On December 31, 2025, Riverview Financial Corp and the reporting person’s spouse disposed of 60,411 and 1,402 shares of Series B preferred stock at $10.70 per share, leaving 169,797 and 3,704 preferred shares, respectively. As of that date, Fields also held 3,483,955 common shares directly, plus additional indirect common holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. insider Randall K. Fields, who serves as Chief Executive Officer, director, and a 10% owner, reported an automatic sale of company stock. On 12/31/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 7,500 shares of common stock at a weighted average price of $12.3449 per share under a pre-established Rule 10b5-1 trading plan. The filing states that this trading plan was set up to help Mr. Fields meet certain charitable commitments. After the reported transaction, Mr. Fields continues to report substantial holdings in ReposiTrak common and preferred stock through multiple entities and family holdings.
ReposiTrak, Inc. director reports stock grant and sales
A director of ReposiTrak, Inc. (TRAK) reported several transactions in the company’s common stock. On November 5, 2025, he acquired 1,265 shares, issued in lieu of cash compensation for his board service for the quarter ended September 30, 2025. On December 22, 2025, he sold 1,641 shares at a weighted average price of $13.1981, and on December 23, 2025 he sold an additional 18,906 shares at a weighted average price of $13.164. After these transactions, he beneficially owned 561,869 shares of ReposiTrak common stock, held directly.
ReposiTrak, Inc. director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025. These shares were issued instead of cash payments for his service on the company’s Board of Directors for the quarter ended September 30, 2025.
After this transaction, he beneficially owned 199,147 shares of common stock directly, 587,476 shares indirectly through a trust, 2,775 shares indirectly through his spouse, and 39,704 shares of Series B preferred stock directly.
ReposiTrak, Inc. chief executive officer, director and 10% owner Randall K. Fields reported small insider stock sales executed under a Rule 10b5-1 trading plan. On 12/22/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 3,000 shares of common stock at a weighted average price of $13.3687 per share. On 12/23/2025, the same entity sold an additional 4,500 shares at a weighted average price of $13.2618 per share. The filing explains that the trading plan was adopted by Fields, in his capacity as trustee of a charitable remainder unitrust, to help meet his charitable commitments. After these sales, Fields continues to beneficially own 3,483,955 shares of common stock directly, plus additional indirect holdings through family and affiliated entities.
TraK (TRAK) insider plans to sell common stock under Rule 144. A notice was filed for the proposed sale of 18,906 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $248,878.58, on or about 12/23/2025 on the NYSE. The issuer has 18,288,455 shares of this class outstanding. The shares to be sold were acquired between 2013 and 2015, mostly as restricted stock vesting under a registered plan in exchange for services, plus an open market purchase for cash. Over the past three months, the same seller disposed of 1,641 common shares for gross proceeds of $21,658.08. The seller represents that he is not aware of undisclosed material adverse information about the issuer.